Mankind Pharma collaborates with OpenAI to drive AI-Enabled transformation across Pharma Value Chain

Bengaluru:  Mankind Pharma, India’s fourth largest pharmaceutical company, today announced a collaboration with OpenAI, a leading AI research and deployment company, to institutionalize AI across its value chain. As one of the first few Indian pharma companies to fully integrate advanced AI into core operations, Mankind aims to accelerate innovation and improve operational efficiency. The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem. Mankind will integrate OpenAI Enterprise across multiple functions, including field force enablement, digital marketing, research and development (R&D), manufacturing, and medical affairs.

In a rapidly evolving healthcare landscape, the ability to transform vast volumes of data into actionable insights, ensure fast and compliant communication, and streamline complex operations is no longer optional—it’s mission-critical. The integration of ChatGPT Enterprise internally addresses these critical needs by empowering Mankind Pharma to leverage OpenAI’s latest models, including GPT-5 to unlock efficiencies and introduce innovative solutions across its entire value chain, from discovery to delivery.

Speaking about this collaboration Arjun Juneja, Chief Operating Officer, Mankind Pharma Ltd. said “At Mankind Pharma, we see working with OpenAI as a pivotal step in building the pharma organization of the future. By integrating advanced AI into our core operations, we’re enabling our teams to move faster, work smarter, and unlock insights that drive real-world impact – whether it’s in field force effectiveness, supply chain agility, or R&D acceleration. This is not just about automation; it’s about creating a more responsive, intelligent, and future-ready enterprise. We’re excited to lead this shift in Indian pharma and set new benchmarks for how technology can drive both operational excellence and long-term value creation.”